1. Home
  2. FKWL vs SNTI Comparison

FKWL vs SNTI Comparison

Compare FKWL & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Wireless Corp.

FKWL

Franklin Wireless Corp.

HOLD

Current Price

$2.58

Market Cap

33.0M

Sector

Utilities

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$0.93

Market Cap

29.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FKWL
SNTI
Founded
1981
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.0M
29.8M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
FKWL
SNTI
Price
$2.58
$0.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$6.00
$8.50
AVG Volume (30 Days)
33.8K
165.9K
Earning Date
05-15-2026
05-06-2026
Dividend Yield
1.10%
N/A
EPS Growth
94.12
77.31
EPS
N/A
N/A
Revenue
$46,086,901.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.14
N/A
P/E Ratio
N/A
N/A
Revenue Growth
49.65
N/A
52 Week Low
$2.58
$0.77
52 Week High
$5.48
$2.88

Technical Indicators

Market Signals
Indicator
FKWL
SNTI
Relative Strength Index (RSI) 23.91 47.11
Support Level N/A $0.87
Resistance Level $3.79 $1.03
Average True Range (ATR) 0.10 0.06
MACD 0.00 -0.00
Stochastic Oscillator 13.95 39.25

Price Performance

Historical Comparison
FKWL
SNTI

About FKWL Franklin Wireless Corp.

Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.

About SNTI Senti Biosciences Inc.

Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).

Share on Social Networks: